Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Dec 23 EFFECT Notice of effectiveness
- 5 Dec 23 POS AM Prospectus update (post-effective amendment)
- 10 Oct 23 424B5 Prospectus supplement for primary offering
- 14 Jun 23 424B5 Prospectus supplement for primary offering
- 12 Jun 23 424B5 Prospectus supplement for primary offering
- 14 Feb 23 424B5 Prospectus supplement for primary offering
- 25 Jan 23 424B5 Prospectus supplement for primary offering
- 25 Jan 23 EFFECT Notice of effectiveness
-
17 Jan 23 S-3 Shelf registration
IRON similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Disc Medicine, Inc. for the registration of its common stock, preferred stock, debt securities, warrants, and units and to the incorporation by reference therein of our report dated March 10, 2022, with respect to the consolidated financial statements of Gemini Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Boston, Massachusetts
January 17, 2023